The annual meeting of the American Heart Association (AHA) held last week in Los Angeles included a great deal of discussion amongst cardiologists of the rising costs to treating heart disease—America’s No. 1 killer.
Heart disease is the leading cause of death for both men and women in the United States, accounting for one of every four deaths, according to the Centers for Disease Control and Prevention. The annual U.S medical costs associated with heart disease is expected to reach $800 billion by 2030, nearly triple the $272 billion spent in 2010.
At the AHA conference there was a great deal of concern expressed over the rising cost of drugs to treat heart disease. The average cost of medication has risen over 27% to treat various conditions related to treat heart disease and the AMA expects that trend to continue well into the future, especially with newer drugs that may offer potential advantages over older drugs to prevent strokes are much more expensive than older treatments.
Some of the top selling drugs in the U.S, such as Lipitor and Plavix, assist in lowering the risk factors of heart disease, but the cost of these medication are many times more expensive for U.S consumers than those in other countries pay. The AHA has expressed concern in the past of the burden prescription drug prices are to those facing heart disease.
At CanadaDrugs.com, many of our patients are dealing with heart disease and look to lower cost options from Canada or the United Kingdom to lower their monthly drug costs.